Edgewise Therapeutics, Inc.
EWTX
Rank in Stocks
#3981
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing... Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
Share Price
$38.12
Market Cap
$4.10B
Change (1 day)
2.50%
Change (1 year)
153.12%
Country
US
Trade Edgewise Therapeutics, Inc. (EWTX)
Category
Healthcare
Stock split history for Edgewise Therapeutics, Inc. (EWTX)
Edgewise Therapeutics, Inc. stock (symbol: EWTX) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 19, 2026.
One EWTX share bought prior to Oct 19, 2026 would equal to 0 EWTX shares today.
The most recent stock split occurred on Oct 19, 2026.
One EWTX share bought prior to Oct 19, 2026 would equal to 0 EWTX shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
